|
1 |
Creative Commons |
The Future of Science Communication |
A look at the past and future of public engagement for scientific information. |
Roger Highfield |
20 Oct 2017 |
|
2 |
Creative Commons |
What Makes a Scientist? |
A look back at historical scientists and their contribution to science. |
Staffan Normark |
20 Oct 2017 |
|
3 |
Creative Commons |
The Future of Artificial Intelligence |
How modern neuroscience is researching the way the human brain can comprehend a working environment. |
Simon Stringer |
19 Oct 2017 |
|
4 |
Creative Commons |
The Future of Publishing |
A talk that focuses on promoting and championing scientific literature. |
Ritu Dhand |
19 Oct 2017 |
|
5 |
Creative Commons |
The Future of Policy and Health Research |
The role of MSD in driving innovation and expanding access to global vaccines. |
Ruxandra Draghia-Akli |
19 Oct 2017 |
|
6 |
Creative Commons |
The Future of the Scientific Community: Challenges and Opportunities |
A scientific discussion with the speakers about the industry and the future of the scientific community. |
John Walker, Story Sylwester, Jo Dally, Ben Goldacre |
19 Oct 2017 |
|
7 |
Creative Commons |
The future of Innovation and Government. |
Creating the future of science by driving innovation in health and life sciences. |
Ruth McKernan |
19 Oct 2017 |
|
8 |
Creative Commons |
The Future of Biotechnology |
Immunocore talk about important issues in oncology and infectious diseases. |
Eliot Forster |
19 Oct 2017 |
|
9 |
Creative Commons |
The Future Of Research |
A look into fundamental discovery and the use of existing scientific knowledge for the benefit of mankind. |
John Walker |
19 Oct 2017 |
|
10 |
|
Equity and commissioning - Richard Sullivan |
Session 4: Equity and commissioning - Richard Sullivan |
Mark Sheehan, Richard Sullivan |
19 Jan 2017 |
|
11 |
|
Equity and commissioning - Muir Gray |
Session 4: Equity and commissioning - Muir Gray |
Muir Gray, Mark Sheehan |
19 Jan 2017 |
|
12 |
|
Data sharing and participation - Jonathan Montgomery |
Session 3: Data sharing and participation - Jonathan Montgomery |
Ingrid Slade, Jonathan Montgomery |
19 Jan 2017 |
|
13 |
|
Data sharing and participation - Anna Middleton |
Session 3: Data sharing and participation - Anna Middleton |
Ingrid Slade, Anna Middleton |
19 Jan 2017 |
|
14 |
|
Data sharing and participation - Mark Lawler |
Session 3: Data sharing and participation - Mark Lawler |
Mark Lawler, Ingrid Slade |
19 Jan 2017 |
|
15 |
|
The human person and the communication of risk - Sian Rees |
Session 2: The human person and the communication of risk - Sian Rees |
Rob Horne, Sian Rees |
19 Jan 2017 |
|
16 |
|
The human person and the communication of risk - Alastair Kent |
Session 2: The human person and the communication of risk - Alastair Kent |
Rob Horne, Alastair Kent |
19 Jan 2017 |
|
17 |
|
The human person and the communication of risk - Joshua Hordern |
Session 2: The human person and the communication of risk - Joshua Hordern |
Joshua Hordern, Rob Horne |
19 Jan 2017 |
|
18 |
|
The promise and the hype of 'personalised medicine' - John Tooke |
Session 1: The promise and the hype of 'personalised medicine' - John Tooke |
Joshua Hordern, John Tooke |
19 Jan 2017 |
|
19 |
|
The promise and the hype of 'personalised medicine' - Steve Sturdy |
Session 1: The promise and the hype of 'personalised medicine' - Steve Sturdy |
Steve Sturdy, Joshua Horden |
19 Jan 2017 |
|
20 |
|
The promise and the hype of 'personalised medicine' - Tim Maughan |
Session 1: The promise and the hype of 'personalised medicine' - Tim Maughan |
Tim Maughan, Joshua Hordern |
19 Jan 2017 |
|
21 |
|
Highlights of Personalised Medicine |
Highlights of Personalised Medicine: the promise, the hype and the pitfalls |
Alastair Kent, Anna Middleton, Marion Lynch, Muir Gray |
19 Jan 2017 |
|
22 |
|
Personalised Medicine, interview with Jonathan Montgomery |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Jonathan Montgomery |
Jonathan Montgomery |
18 Jan 2017 |
|
23 |
|
Personalised Medicine, interview with Anna Middleton |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Anna Middleton |
Anna Middleton |
18 Jan 2017 |
|
24 |
|
Personalised Medicine, interview with Marion Lynch |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Marion Lynch |
Marion Lynch |
18 Jan 2017 |
|
25 |
|
Personalised Medicine, interview with Mark Lawler |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Mark Lawler |
Mark Lawler |
18 Jan 2017 |
|
26 |
|
Personalised Medicine, interview with Alastair Kent |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Alastair Kent |
Alastair Kent |
18 Jan 2017 |
|
27 |
|
Personalised Medicine, interview with Rick Kaplan |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Rick Kaplan |
Rick Kaplan |
18 Jan 2017 |
|
28 |
|
Personalised Medicine, interview with Muir Gray |
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Muir Gray |
Muir Gray |
18 Jan 2017 |
|
29 |
|
Deadly Devices and Dangerous Drugs, the Secrets Behind Medical Research |
A talk hosted by Kellogg College and the Centre for Evidence-Based Medicine at the University Museum of Natural History, as part of the University's Alumni Weekend. |
Carl Heneghan, Jeff Aronson, Deb Cohen, Ben Goldacre |
03 Oct 2014 |
|
30 |
|
The Flipside of Scientific Freedom |
Scientists have always had to contend with the idea that their research may be misused. The problem, weighing scientific freedom of inquiry against the possibility that research could be used for harm, is known as the 'dual-use dilemma'. |
Tom Douglas |
12 Aug 2009 |
|
31 |
|
What is Science for? |
What is science for, what good does it do and should it do good? |
John Sulston, John Harris, Richard Dawkins |
10 Jun 2008 |
